Search

Background and Aim: Some pathogens that cause infections in cattle are found in wild artiodactyls. Their prevalence, possible impact on the population of free-living animals, and the spread of infectious pathology in livestock have yet to be studied. We investigated the occurrence of bovine herpesviruses (BoHV-1, BoHV-4, and BoHV-6) among wild moose and roe deer in 8 areas of the Moscow region in the Russian Federation., Materials and Methods: One hundred and one tissue samples and nasal swabs of 24 moose and seven roe deer were studied using a real-time polymerase chain reaction (PCR) for BoHV-1 DNA and conventional PCR for BoHV-4 and BoHV-6 DNA. A virus neutralization test (VNT) was used to detect antibodies to BoHV-1 in 19 serum samples. The final antibody titer was calculated with the Spearman-Kärber method., Results: BoHV-4 and BoHV-6 DNA were not detected in all studied samples of 31 animals. BoHV-1 DNA was detected using a real-time PCR in nasal swabs from 2 adult roe deer. For BoHV-1, only 9/19 tested serum samples reacted positive in VNT with the titer range from 0.67 ± 0.19 to 3.75 ± 0.10 log2. Antibodies were detected in all age groups, more often in fawns under 1-year-old. The seropositivity of females was higher than in males., Conclusion: Wild ungulates can potentially represent a reservoir of new pathogenic livestock viruses. To study the prevalence and genetic diversity of wild ungulate herpesviruses, detailed molecular studies of the cervid herpesvirus 1, cervid herpesvirus 2, and elk herpesvirus 1 are necessary., Competing Interests: The authors declare that they have no competing interests., (Copyright: © Yatsentyuk, et al.)

Metformin is a first-line antidiabetic drug for the treatment of type 2 diabetes mellitus (DM2); its molecular target is AMP-activated protein kinase (AMPK), which is involved in many metabolic processes. Metformin not only reduces blood glucose levels and improves insulin sensitivity, but also inhibits lipolysis and reduces cardiovascular risk in patients with DM2. In recent years, it has been proven that metformin slows down the aging process, stimulates hair growth, eliminates cognitive impairment, and also has an antitumor effect. Most basic studies have shown that metformin inhibits the growth of tumor cells and promotes cellular apoptosis, while clinical studies show contradictory results. This discrepancy can be explained by the difference in the concentration of metformin between basic and clinical studies. The maximum daily dose of metformin for patients with DM2 is 2500 mg / day, and the dose used in basic research was much higher. Metformin directly activates the AMPK signaling pathway, inhibits the production of reactive oxygen species, induces the activation of mTORC1, inhibits cyclin D1, which leads to a reduction in the risk of the occurrence and development of malignant neoplasms. In addition, metformin indirectly inhibits tumor growth, proliferation, invasion and metastasis by reducing the concentration of glucose in the blood, insulin resistance, as well as by reducing inflammation and affecting the tumor microenvironment. Glycolysis plays an important role in the energy metabolism of tumors, and metformin is able to have an inhibitory effect on it. Currently, studies of the mechanism of antitumor effects of metformin are becoming more extensive and in-depth, but there are still some contradictions.

28 children with concomitant strabismus were examined using complex ultrasonography. Thickness of horizontal recti muscles was estimated in convergent and divergent strabismus. The blood flow in central retinal artery was estimated in patients with concomitant strabismus.

The paper gives the comparative results of infrared exposure, drug and multimodality treatment in partial optic nerve atrophy of varying degrees, as evidenced by Doppler, electrophysiological, and morphometric studies.